Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ark Genomic Revolution ETF (NY: ARKG )

32.60 UNCHANGED
Streaming Delayed Price Updated: 4:10 PM EDT, May 20, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 576
Open 32.60
Bid (Size) 32.63 (47)
Ask (Size) 33.20 (4)
Prev. Close 32.60
Today's Range 32.60 - 32.60
52wk Range 27.47 - 94.14
Shares Outstanding 794,550
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Know The 2 Healthcare Companies Cathie Wood's Ark Invest Bought On Friday
Cathie Wood's Ark Invest may have had a disappointing 2021, but the fund's purchases/liquidations are always watched keenly by investors. On Friday, ETFs managed by... 
Via Benzinga
Tesla Bull Cathie Wood Bought $1M Shares In This Biotech Stock Today
Tesla Inc (NASDAQ: TSLA) bull Cathie Wood led Ark Investment Management on Thursday further raised its exposure in China-based biotech company Burning Rock Biotech Ltd (NASDAQ: BNR). 
Via Benzinga

Performance

YTD
-48.47%
-48.47%
1 Month
-14.66%
-14.66%
3 Month
-26.29%
-26.29%
6 Month
-49.90%
-49.90%
1 Year
-58.76%
-58.76%

More News

Read More
4 Big Ark Innovation Components Report Earnings This Week: Could It Spell More Danger For Cathie Wood?
Via Benzinga
Psyched: Cathie Wood Invests In Psychedelics Co ATAI, Bill Approved in Utah, AI Startup To 'Design States Of Mind'
Via Benzinga
Cathie Wood Is Buying this Peter Thiel-Backed Psychedelics Stock For Ark Funds
Via Benzinga
A Leaky ARKK
Via Talk Markets
Neck Cream Reversal
Via Talk Markets
Cathie Wood's Ark Invest Sheds Stake In This Large-Cap Pharma Ahead Of Earnings
Via Benzinga
Ark Funds Launching New Fund That Could Invest In Private Companies
Via Talk Markets
Ark Funds Launching New Fund That Could Invest In Private Companies
Via Benzinga
Small Cap Biotech Stocks: Is it time to start trading?
Via Talk Markets
Benzinga Asks: Which ARK Fund Would You Rather Buy And Hold For 5 Years?
Via Benzinga
UiPath Stock Is Worth Believing in Here as Wood Holds Fast
Via InvestorPlace
Biotech Playbook 2021 Part 2: Rotation Rally Brings Relief after FED Pivot
Via Talk Markets
Cathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday
Via Benzinga
Biotech Playbook 2021: No Help From Small Caps In Q4
Via Talk Markets
Bionano Genomics Proves Not Everything Genetic is Gold
Via InvestorPlace
Cathie Wood Testing 'ARK On Steroids' As ARK Funds Struggle
Via Investor's Business Daily
Topics Electric Vehicles
Exposures Electric Vehicles
Don't Look Now, But Cathie Wood's Ark Is Taking On Water
Via Talk Markets
Biotech Stocks are Due for a Rally
Via Talk Markets
Yes, Cathie Wood's $700,000 Bitcoin Price Prediction Is Legit
Via Talk Markets
Tesla (TSLA) Not Enough To Lift ARK Innovation (ARKK)
Via Talk Markets
Topics Stocks
Exposures US Equities
ETF Battles: Finding the Top Genomics Biotech ETF – A Triple Header of ARKG vs IDNA vs GNOM
Via Talk Markets
Ginkgo Bioworks Stock Drops 20% After Short Sellers Call Company A 'Colossal Scam'
Via Benzinga
Mike Khouw Sees Unusual Options Activity In ARK Genomic Revolution ETF
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.